Lactobacillus acidophilus – LA02 (DSM 21717)
Rebalance of intestinal microbiota • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus acidophilus – LA02 (DSM 21717) Read More »
Lactobacillus
Lactobacillus acidophilus – LA06 (DSM 23033)
Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) productionScientific support
Lactobacillus acidophilus – LA06 (DSM 23033) Read More »
Lactobacillus brevis – LBR01 (DSM 23034)
Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus brevis – LBR01 (DSM 23034) Read More »
Lactobacillus reuteri (formerly buchneri) – Lb26 (DSM 16341)
Under worldwide exclusive license from BIOMAN for nutraceutical and pharma applications Carrier of selenium with high bioavailability • Organic selenium from probiotic strain allergen free with High Bioavailability: Protection of DNA, proteins and lipids from oxidative damage • Normal function of the immune system • Maintenance of normal bone • Normal cognitive function
Lactobacillus reuteri (formerly buchneri) – Lb26 (DSM 16341) Read More »
Lactobacillus crispatus – LCR01 (DSM 24619)
Vaginal health • Rebalance of a healthy vaginal microbiota
Lactobacillus crispatus – LCR01 (DSM 24619) Read More »
Lactobacillus delbrueckii subsp. bulgaricus – LDB01 (DSM 16606)
Rebalance of intestinal microbiota
Lactobacillus delbrueckii subsp. bulgaricus – LDB01 (DSM 16606) Read More »
Lactobacillus delbrueckii subsp. delbrueckii – LDD01 (DSM 22106)
Gaseous colic • Inhibition of E. coli, including toxinogenic O157:H7 • Inhibition of Klebsiella pneumoniae and of different coliforms isolated from colicky infants • Inhibition of pathogens E. coli, Klebsiella and gas-producing coliforms
Lactobacillus delbrueckii subsp. delbrueckii – LDD01 (DSM 22106) Read More »
Lactobacillus fermentum – LF5 (CNCM I-789)
Vaginal health • Inhibition of Candida strains • Treatment of vulvovaginal candidiasis (VVC)
Lactobacillus fermentum – LF5 (CNCM I-789) Read More »
Lactobacillus fermentum – LF08 (DSM 18297)
Inhibition of Candida strains
Lactobacillus fermentum – LF08 (DSM 18297) Read More »
Lactobacillus fermentum – LF09 (DSM 18298)
Inhibition of pathogenic Candida species • Restoration of a physiological gut barrier • Inhibition of Candida growth • Strain from brushing of the gut mucosa
Lactobacillus fermentum – LF09 (DSM 18298) Read More »
Lactobacillus fermentum – LF11 (DSM 19188)
Inhibition of pathogenic Candida species • Vaginal health • Inhibition of Candida strains • Counteraction of vulvovaginal candidiasis (VVC)
Lactobacillus fermentum – LF11 (DSM 19188) Read More »
Lactobacillus fermentum – LF16 (DSM 26856)
Vaginal health • Inhibition of Candida growth
Lactobacillus fermentum – LF16 (DSM 26856) Read More »
Lactobacillus fermentum – ME-3 (DSM 14241)
Under license from the University of Tartu for food applications Cardiovascular health • LDL-cholesterol lowering • Antioxidant properties
Lactobacillus fermentum – ME-3 (DSM 14241) Read More »
Lactobacillus gasseri – LGS06 (DSM 32405)
Weight management • Vaginal health • Rebalance of a healthy vaginal microbiota
Lactobacillus gasseri – LGS06 (DSM 32405) Read More »
Lactobacillus paracasei – LPC00 (LMG P-21380)
Rebalance of intestinal microbiota
Lactobacillus paracasei – LPC00 (LMG P-21380) Read More »
Lactobacillus paracasei – LPC09 (DSM 24243)
Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus paracasei – LPC09 (DSM 24243) Read More »
Lactobacillus plantarum – LP01 (LMG P-21021)
Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus plantarum – LP01 (LMG P-21021) Read More »
Lactobacillus plantarum – LP02 (LMG P-21020)
Cystitis • Inhibition of E. coli
Lactobacillus plantarum – LP02 (LMG P-21020) Read More »
Lactobacillus plantarum – LP09 (DSM 25710)
Anti-pathogen activity
Lactobacillus plantarum – LP09 (DSM 25710) Read More »
Lactobacillus reuteri – LRE02 (DSM 23878)
Production of reuterin and vitamin B12 • Anti-pathogen activity and immunostimulation (induction of IFN-gamma) • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus reuteri – LRE02 (DSM 23878) Read More »
Lactobacillus reuteri – LRE03 (DSM 22106)
Production of reuterin • Immunostimulation with induction of IFN-γ
Lactobacillus reuteri – LRE03 (DSM 22106) Read More »
Lactobacillus rhamnosus – GG (ATCC 53103)
Diarrhea • Rotaviral diarrhea • Gastroenteritis Also available as Active Pharmaceutical Ingredient (API) Autism and ADH prevention • Oral health • Caries prevention • Inhibition of Streptococcus mutans
Lactobacillus rhamnosus – GG (ATCC 53103) Read More »
Lactobacillus rhamnosus – LR04 (DSM 16605)
Diarrhea • Inhibition of E. coli, including enterohemorrhagic O157:H7 • Cystitis • Inhibition of E. coli
Lactobacillus rhamnosus – LR04 (DSM 16605) Read More »
Lactobacillus rhamnosus – LR06 (DSM 21981)
Inhibition of E. coli • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus rhamnosus – LR06 (DSM 21981) Read More »
Lactobacillus salivarius – CRL1328
Inhibition of Enterococcus faecalis, Enterococcus faecium and Neisseria gonorrhoeae • Vaginal health • Prevention of urogenital infections • Inhibition of Candida
Lactobacillus salivarius – CRL1328 Read More »
Lactobacillus salivarius – LS01 (DSM 22775)
Treatment of atopic dermatitis • Improvement of the Quality of Life in subjects with Atopic Dermatitis • Skin health • Inhibition of C. acnes (formerly classified as P. acnes) – induced IL-8 release. Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus salivarius – LS01 (DSM 22775) Read More »
Lactobacillus salivarius – LS03 (DSM 22776)
Acne – Anti-pathogen activity: inhibition of C. acnes (formerly classified as P. acnes) and its induction of IL-8 • Immunomodulation • Strong adhesion to the intestinal mucosa
Lactobacillus salivarius – LS03 (DSM 22776) Read More »
Lactobacillus plantarum P 17630
Prevention of vaginal infections, restoring the healthy vaginal microflora. In case of acute vaginal infection, used as a maintenance treatment, after a medical therapy. Topical treatment of vaginal infections such as vaginitis and vaginosis, including vulvovaginal candidiasis. Restoration of vaginal microflora during antibiotic or chemotherapy treatments. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium).
Lactobacillus plantarum P 17630 Read More »
Lactobacillus salivarius I 1794
Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at
Lactobacillus salivarius I 1794 Read More »
Lactobacillus paracasei P 30020
Recurrent cystitis. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 30020. Isolated from goat’s milk. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf life raw material: 12 months when stored below 8°C.
Lactobacillus paracasei P 30020 Read More »
Lactobacillus paracasei I 1688
Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at
Lactobacillus paracasei I 1688 Read More »
Lactobacillus paracasei I 1687
Immunomodulatory activity. Deposited at the International Culture Collection CNCM – Institute Pasteur (Paris). Deposit N°CNCM I 1687. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf-life raw material: 12 months when stored below -20°C or 6 months when stored
Lactobacillus paracasei I 1687 Read More »
Lactobacillus plantarum CVI15B
Immunomodulatory activity. Deposited at the International Culture Collection CNCM – Institute Pasteur (Paris). Deposit N°LMG P 30023 Isolated from a cabbage. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf-life raw material: 12 months when stored below -20°C or 6 months when stored below
Lactobacillus plantarum CVI15B Read More »
Lactobacillus rhamnosus ATCC-53103
Immunomodulatory activity. Anti-inflammatory activity. Deposited at the American Type Culture Collection ATCC-53103. Deposit N°ATCC-53103. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf-life raw material: 12 months when stored below 8°C. Also available as Active Pharmaceutical Product (API)
Lactobacillus rhamnosus ATCC-53103 Read More »
Lactobacillus delbrueckii P 18805
Allergy. Intestinal dysmicrobisms caused by antibiotic therapies. Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhea, non-specific enteritis, colitis). Traveler’s diarrhea prevention. They are deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 18805. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural
Lactobacillus delbrueckii P 18805 Read More »
Lactobacillus crispatus P 17631
Treatment of skin manifestations associated with Malassezia spp. such as seborrheic dermatitis and pityriasis versicolor, caused by an imbalance of the skin microbiota. OILY SUSPENSION Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 17631. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural
Lactobacillus crispatus P 17631 Read More »
Lactobacillus acidophilus P 18806
Allergy. Intestinal dysmicrobisms caused by antibiotic therapies. Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhea, non-specific enteritis, colitis). Traveler’s diarrhea prevention. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 18806. Isolated from healthy human environment. The microbial strain is not genetically modified and it is of natural origin (OMG
Lactobacillus acidophilus P 18806 Read More »
Lactobacillus paracasei LC18
Balance of the intestinal flora. It helps the normal function of the neuron system and psychological function. It also contributes to the normal cognitive function. L. plantarum LM2 and L. brevis Y1 produce, respectively, Acetylcholine (Ach) and Gamma-aminobutyric acid (GABA), inhibitory neurotransmitter. It has an immunomodulating action, it helps reinforce the body’s natural defenses and
Lactobacillus paracasei LC18 Read More »
Lactobacillus brevis Y1
Balance of the intestinal flora. It helps the normal function of the neuron system and psychological function. It also contributes to the normal cognitive function. L. plantarum LM2 and L. brevis Y1 produce, respectively, Acetylcholine (Ach) and Gamma-aminobutyric acid (GABA), inhibitory neurotransmitter. It has an immunomodulating action, it helps reinforce the body’s natural defenses and
Lactobacillus brevis Y1 Read More »
